Plain-English translation of NCT05363761 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medical device called the Neurotronic Infusion Catheter, which is designed to treat type 2 diabetes and high blood pressure by using a minimally invasive procedure. The device works by delivering chemical treatment to specific blood vessels (your kidney and liver arteries) to reduce nerve signals that may contribute to these conditions. Researchers want to see if this treatment is safe and effective for patients whose diabetes or blood pressure aren't fully controlled with current medications.
Current medications help many people with type 2 diabetes and high blood pressure, but some patients still struggle to reach their treatment goals or experience side effects. This trial exists to test whether targeting the nerves around specific blood vessels through a catheter procedure might offer a new option for better control of these conditions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo a minimally invasive catheter procedure in which doctors thread a small tube through an artery to reach your kidney and/or liver arteries and deliver chemical treatment to the nerves there. The procedure is similar to a cardiac catheterization. You would need to visit the study center for the procedure and follow-up visits to have your blood sugar, blood pressure, and overall health monitored to see how the treatment works and to check for any side effects.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Panama
Paraguay